S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
OTCMKTS:BIOQ

Bioqual Stock Forecast, Price & News

$100.00
0.00 (0.00%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$100.00
$100.00
50-Day Range
$83.00
$100.00
52-Week Range
$70.00
$100.00
Volume
N/A
Average Volume
64 shs
Market Capitalization
$90 million
P/E Ratio
15.06
Dividend Yield
1.25%
Beta
-0.39
30 days | 90 days | 365 days | Advanced Chart
Receive BIOQ News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioqual and its competitors with MarketBeat's FREE daily newsletter.


Bioqual logo

About Bioqual

Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. It focuses on animal models of human diseases including COVID-19, Zika, AIDS, Influenza, RSV, Malaria, and other infectious disease areas. The company was founded by John C. Landon on June 1, 1981 and is headquartered in Rockville, MD.

Headlines

Head-To-Head Survey: Bioqual (BIOQ) versus The Competition
November 30, 2021 |  americanbankingnews.com
Critical Review: Bioqual (BIOQ) and Its Competitors
November 29, 2021 |  americanbankingnews.com
Bioqual (BIOQ) and Its Peers Head to Head Review
November 27, 2021 |  americanbankingnews.com
Bioqual (BIOQ) vs. Its Peers Head to Head Review
November 27, 2021 |  americanbankingnews.com
Comparing Bioqual (BIOQ) & Its Competitors
November 27, 2021 |  americanbankingnews.com
Comparing Bioqual (BIOQ) and Its Peers
November 26, 2021 |  americanbankingnews.com
Bioqual (BIOQ) and Its Competitors Critical Survey
November 21, 2021 |  americanbankingnews.com
Bioqual (BIOQ) versus Its Competitors Head-To-Head Review
November 19, 2021 |  americanbankingnews.com
Analyzing Bioqual (BIOQ) and The Competition
November 18, 2021 |  americanbankingnews.com
Contrasting Bioqual (BIOQ) & Its Competitors
November 16, 2021 |  americanbankingnews.com
Bioqual (BIOQ) vs. The Competition Head-To-Head Comparison
November 15, 2021 |  americanbankingnews.com
Bioqual (BIOQ) and The Competition Critical Analysis
November 13, 2021 |  americanbankingnews.com
Analyzing Bioqual (BIOQ) & Its Peers
November 13, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BIOQ
CUSIP
09065J101
Fax
N/A
Employees
114
Year Founded
N/A

Sales & Book Value

Annual Sales
$57.68 million

Profitability

Net Income
$6.33 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
544,000
Market Cap
$90 million
Optionable
Not Optionable

Company Calendar

Last Earnings
9/17/2021
Ex-Dividend
9/28/2021
Dividend Payable
10/20/2021
Today
12/03/2021
Next Earnings (Estimated)
1/20/2022
Fiscal Year End
5/31/2022

MarketRank

Overall MarketRank

1.70 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Bioqual (OTCMKTS:BIOQ) Frequently Asked Questions

How has Bioqual's stock been impacted by Coronavirus?

Bioqual's stock was trading at $51.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIOQ shares have increased by 93.2% and is now trading at $100.00.
View which stocks have been most impacted by COVID-19
.

When is Bioqual's next earnings date?

Bioqual is scheduled to release its next quarterly earnings announcement on Thursday, January 20th 2022.
View our earnings forecast for Bioqual
.

How were Bioqual's earnings last quarter?

Bioqual, Inc. (OTCMKTS:BIOQ) announced its earnings results on Friday, September, 17th. The company reported $2.38 earnings per share (EPS) for the quarter. The firm had revenue of $16.61 million for the quarter.
View Bioqual's earnings history
.

How often does Bioqual pay dividends? What is the dividend yield for Bioqual?

Bioqual declared an annual dividend on Tuesday, September 21st. Investors of record on Wednesday, September 29th will be given a dividend of $1.25 per share on Wednesday, October 20th. This represents a dividend yield of 1.48%. The ex-dividend date is Tuesday, September 28th.
View Bioqual's dividend history
.

Is Bioqual a good dividend stock?

Bioqual pays an annual dividend of $1.25 per share and currently has a dividend yield of 1.25%. The dividend payout ratio of Bioqual is 18.83%. This payout ratio is at a healthy, sustainable level, below 75%.
View Bioqual's dividend history.

Who are Bioqual's key executives?

Bioqual's management team includes the following people:
  • Mark G. Lewis, Chairman, President & Chief Executive Officer
  • Mitchell Franklin, Chief Operating Officer & Secretary
  • David A. Newcomer, Chief Financial Officer
  • Chander P. Sarma, Chief Information Officer
  • Nancy A. Madden, Vice President-Administration Operations

What is Bioqual's stock symbol?

Bioqual trades on the OTCMKTS under the ticker symbol "BIOQ."

How do I buy shares of Bioqual?

Shares of BIOQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bioqual's stock price today?

One share of BIOQ stock can currently be purchased for approximately $100.00.

How much money does Bioqual make?

Bioqual has a market capitalization of $90 million and generates $57.68 million in revenue each year. The company earns $6.33 million in net income (profit) each year or $6.64 on an earnings per share basis.

How many employees does Bioqual have?

Bioqual employs 114 workers across the globe.

What is Bioqual's official website?

The official website for Bioqual is www.bioqual.com.

Where are Bioqual's headquarters?

How can I contact Bioqual?

Bioqual's mailing address is 9600 Medical Center Drive Suite 101, ROCKVILLE MD, 20850. The company can be reached via phone at (240) 404-7654 or via email at [email protected].


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.